content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001856296</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001635088</issuerCik>
        <issuerName>Roivant Sciences Ltd.</issuerName>
        <secFileNumber>001-40782</secFileNumber>
        <issuerAddress>
          <com:street1>c/o Roivant Sciences Ltd. 7th Floor</com:street1>
          <com:street2>50 broadway</com:street2>
          <com:city>london</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H 0DB</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>44207 400 3347</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Kumar Rakhi</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Officer</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>ROCKEFELLER FINANCIAL, LLC</name>
          <address>
            <com:street1>45 ROCKEFELLER PLAZA - FLOOR 5</com:street1>
            <com:city>NEW YORK</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10111</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>71989</noOfUnitsSold>
        <aggregateMarketValue>609829.07</aggregateMarketValue>
        <noOfUnitsOutstanding>758427350</noOfUnitsOutstanding>
        <approxSaleDate>04/28/2023</approxSaleDate>
        <securitiesExchangeName>nasdaq</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>common</securitiesClassTitle>
        <acquiredDate>04/28/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Options Exercise - Grant Date - 4/20/2022</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>71989</amountOfSecuritiesAcquired>
        <paymentDate>04/28/2023</paymentDate>
        <natureOfPayment>wire</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar</name>
          <address>
            <com:street1>c/o Roivant Sciences Ltd. 7th Floor</com:street1>
            <com:street2>50 broadway</com:street2>
            <com:city>london</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>common</securitiesClassTitle>
        <saleDate>02/21/2023</saleDate>
        <amountOfSecuritiesSold>3103</amountOfSecuritiesSold>
        <grossProceeds>26747.86</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar</name>
          <address>
            <com:street1>c/o Roivant Sciences Ltd. 7th Floor</com:street1>
            <com:street2>50 broadway</com:street2>
            <com:city>london</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>common</securitiesClassTitle>
        <saleDate>03/20/2023</saleDate>
        <amountOfSecuritiesSold>3098</amountOfSecuritiesSold>
        <grossProceeds>26983.58</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar</name>
          <address>
            <com:street1>c/o Roivant Sciences Ltd. 7th floor</com:street1>
            <com:street2>50 broadway</com:street2>
            <com:city>london</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>common</securitiesClassTitle>
        <saleDate>04/26/2023</saleDate>
        <amountOfSecuritiesSold>87830</amountOfSecuritiesSold>
        <grossProceeds>762283.86</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar</name>
          <address>
            <com:street1>c/o Roivant Sciences Ltd. 7th floor</com:street1>
            <com:street2>50 broadway</com:street2>
            <com:city>london</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>common</securitiesClassTitle>
        <saleDate>04/27/2023</saleDate>
        <amountOfSecuritiesSold>70969</amountOfSecuritiesSold>
        <grossProceeds>603673.00</grossProceeds>
      </securitiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>04/28/2023</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>02/25/2023</planAdoptionDate>
        </planAdoptionDates>
        <signature>Jason coleman as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Rakhi Kumar</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 5617}]
text: 144
  0001856296
  XXXXXXXX
  LIVE
  0001635088
  Roivant Sciences Ltd.
  001-40782
  c/o Roivant Sciences Ltd. 7th Floor
  50 broadway
  london
  X0
  SW1H 0DB
  44207 400 3347
  Kumar Rakhi
  Officer
  common
  ROCKEFELLER FINANCIAL, LLC
  45 ROCKEFELLER PLAZA - FLOOR 5
  NEW YORK
  NY
  10111
  71989
  609829.07
  758427350
  04/28/2023
  nasdaq
  common
  04/28/2023
  Options Exercise - Grant Date - 4/20/2022
  Roivant Sciences Ltd
  N
  71989
  04/28/2023
  wire
  N
  Rakhi Kumar
  c/o Roivant Sciences Ltd. 7th Floor
  50 broadway
  london
  X0
  SW1H 0DB
  common
  02/21/2023
  3103
  26747.86
  Rakhi Kumar
  c/o Roivant Sciences Ltd. 7th Floor
  50 broadway
  london
  X0
  SW1H 0DB
  common
  03/20/2023
  3098
  26983.58
  Rakhi Kumar
  c/o Roivant Sciences Ltd. 7th floor
  50 broadway
  london
  X0
  SW1H 0DB
  common
  04/26/2023
  87830
  762283.86
  Rakhi Kumar
  c/o Roivant Sciences Ltd. 7th floor
  50 broadway
  london
  X0
  SW1H 0DB
  common
  04/27/2023
  70969
  603673.00
  04/28/2023
  02/25/2023
  Jason coleman as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Rakhi Kumar